380 related articles for article (PubMed ID: 18990491)
1. Occurrence of pharmaceutically active compounds during 1-year period in wastewaters from four wastewater treatment plants in Seville (Spain).
Santos JL; Aparicio I; Callejón M; Alonso E
J Hazard Mater; 2009 May; 164(2-3):1509-16. PubMed ID: 18990491
[TBL] [Abstract][Full Text] [Related]
2. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain).
Santos JL; Aparicio I; Alonso E
Environ Int; 2007 May; 33(4):596-601. PubMed ID: 17084895
[TBL] [Abstract][Full Text] [Related]
3. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.
Lishman L; Smyth SA; Sarafin K; Kleywegt S; Toito J; Peart T; Lee B; Servos M; Beland M; Seto P
Sci Total Environ; 2006 Aug; 367(2-3):544-58. PubMed ID: 16697441
[TBL] [Abstract][Full Text] [Related]
4. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden.
Bendz D; Paxéus NA; Ginn TR; Loge FJ
J Hazard Mater; 2005 Jul; 122(3):195-204. PubMed ID: 15967274
[TBL] [Abstract][Full Text] [Related]
5. Occurrence and removal of pharmaceutically active compounds in sewage treatment plants with different technologies.
Ying GG; Kookana RS; Kolpin DW
J Environ Monit; 2009 Aug; 11(8):1498-505. PubMed ID: 19657534
[TBL] [Abstract][Full Text] [Related]
6. Occurrence and fate of anti-inflammatory drugs in wastewater treatment plants in Japan.
Nakada N; Komori K; Suzuki Y
Environ Sci; 2005; 12(6):359-69. PubMed ID: 16609674
[TBL] [Abstract][Full Text] [Related]
7. Occurrence and removal of PPCPs in municipal and hospital wastewaters in Greece.
Kosma CI; Lambropoulou DA; Albanis TA
J Hazard Mater; 2010 Jul; 179(1-3):804-17. PubMed ID: 20395039
[TBL] [Abstract][Full Text] [Related]
8. Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures.
Sim WJ; Lee JW; Lee ES; Shin SK; Hwang SR; Oh JE
Chemosphere; 2011 Jan; 82(2):179-86. PubMed ID: 21040946
[TBL] [Abstract][Full Text] [Related]
9. Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, beta-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment.
Paxéus N
Water Sci Technol; 2004; 50(5):253-60. PubMed ID: 15497855
[TBL] [Abstract][Full Text] [Related]
10. Carbamazepine, diclofenac, ibuprofen and bezafibrate--investigations on the behaviour of selected pharmaceuticals during wastewater treatment.
Strenn B; Clara M; Gans O; Kreuzinger N
Water Sci Technol; 2004; 50(5):269-76. PubMed ID: 15497857
[TBL] [Abstract][Full Text] [Related]
11. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants.
Clara M; Strenn B; Gans O; Martinez E; Kreuzinger N; Kroiss H
Water Res; 2005 Nov; 39(19):4797-807. PubMed ID: 16242170
[TBL] [Abstract][Full Text] [Related]
12. Removal of pharmaceuticals in secondary wastewater treatment processes in Taiwan.
Lin AY; Yu TH; Lateef SK
J Hazard Mater; 2009 Aug; 167(1-3):1163-9. PubMed ID: 19269086
[TBL] [Abstract][Full Text] [Related]
13. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
Radjenović J; Petrović M; Barceló D
Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of pharmaceutically active compounds in surface waters of the Henares-Jarama-Tajo River system (Madrid, Spain) and a potential risk characterization.
Fernández C; González-Doncel M; Pro J; Carbonell G; Tarazona JV
Sci Total Environ; 2010 Jan; 408(3):543-51. PubMed ID: 19889447
[TBL] [Abstract][Full Text] [Related]
15. Occurrence and fate of pharmaceuticals in wastewater treatment plants and rivers in Korea.
Sim WJ; Lee JW; Oh JE
Environ Pollut; 2010 May; 158(5):1938-47. PubMed ID: 19913963
[TBL] [Abstract][Full Text] [Related]
16. Occurrence and removal of pharmaceuticals in wastewater treatment plants at the Spanish Mediterranean area of Valencia.
Gracia-Lor E; Sancho JV; Serrano R; Hernández F
Chemosphere; 2012 Apr; 87(5):453-62. PubMed ID: 22221664
[TBL] [Abstract][Full Text] [Related]
17. Occurrence and removal of pharmaceuticals, caffeine and DEET in wastewater treatment plants of Beijing, China.
Sui Q; Huang J; Deng S; Yu G; Fan Q
Water Res; 2010 Jan; 44(2):417-26. PubMed ID: 19674764
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive assessment of the design configuration of constructed wetlands for the removal of pharmaceuticals and personal care products from urban wastewaters.
Hijosa-Valsero M; Matamoros V; Sidrach-Cardona R; Martín-Villacorta J; Bécares E; Bayona JM
Water Res; 2010 Jun; 44(12):3669-78. PubMed ID: 20494393
[TBL] [Abstract][Full Text] [Related]
19. Removal of pharmaceutically active compounds in nitrifying-denitrifying plants.
Suárez S; Ramil M; Omil F; Lema JM
Water Sci Technol; 2005; 52(8):9-14. PubMed ID: 16312946
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of pharmaceutically active compounds on the Guadalquivir River basin (Spain): occurrence and risk assessment.
Martín J; Camacho-Muñoz D; Santos JL; Aparicio I; Alonso E
J Environ Monit; 2011 Jul; 13(7):2042-9. PubMed ID: 21666922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
